$564.8-0.59%. However, solely looking at the historical price movement is usually misleading. From AI system, total return is 389.47% from 566 forecasts. Stay on top with forecast models models trained, tested, and updated every day. While most stocks have plunged in the coronavirus-caused stock market crash, Regeneron's shares have jumped more than 20%. Most Recent Rating. Regeneron Pharmaceuticals (REGN) is bucking the market trend and presenting bullish charts as the biopharma giant's work on a Covid-19 antibody treatment is helping move its shares in a … REGN stock outlook ; REGN stock chart overview; Should I buy Regeneron Pharmaceuticals stock? About the Regeneron Pharmaceuticals, Inc. stock forecast. Investors can use this … Regeneron Pharmaceuticals Inc stock has risen 115.41% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives REGN stock a score of 72 out of a possible 100.. That rank is primarily influenced by a long-term technical score of 93. Over the last 30 days, this security got 1 buy, 0 sell and 1 hold ratings. TipRanks | Stock Market Research, News and Analyst Forecast. Will Regeneron Pharmaceuticals Inc. stock go up? After running up to highs in July, the stock has been in a steady downtrend, which accelerated to the downside to meet the larger trendline. Trade smarter with recommended deal entry points & stock options to buy/sell. How is Regeneron Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 23 analysts? Become a more powerful trader with our transparent stock forecasts. The 'recent weakness in [Regeneron's stock] is overlooking the pace of Dupixent’s growth and expansion potential,' Citi said, upgrading the stock. Skip to content. Close on Oct 2nd, 2020. stock market prediction; REGN forecast; Regeneron Pharmaceuticals Inc. (REGN) stock prediction . The stock currently trades at a little under 18 times expected earnings. As of 2021 January 04, Monday current price of REGN stock is 483.200$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Regeneron Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Regeneron Stock Forecast: Bullish Long Term Buy For This Undervalued Stock. This Buy consensus rating has held steady for over two years. REGN Stock: Constructive Developments Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported earnings on May 4, 2017, and although it missed on the bottom line, REGN stock is … 3 months performance-11.20%. Stocks; IPOs; News; Actions; Blog ; Search Home » Stocks » REGN. Last 30 Days . According to present data Regeneron Pharmaceuticals's RGO shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). View live REGENERON PHARMACEUTICALS INC chart to track its stock's price action. Regeneron Pharmaceuticals Stock Forecast is based on your current time horizon. Regeneron Pharmaceuticals, Inc. Common Stock (REGN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. REGENERON PHARMACEUTICALS : Forcasts, revenue, earnings, analysts expectations, ratios for REGENERON PHARMACEUTICALS Stock | REGN | Access longer forecasts & trade recommendations. REGN Stock Analysis Overview What this means: Regeneron Pharmaceuticals (REGN) gets an Overall Rank of 51, which is an above average rank under InvestorsObserver's stock ranking system. The median estimate represents a +39.69% increase from the last price of 483.21. Regeneron Pharmaceuticals Inc. stock outperforms market despite losses on the day Jan. 4, 2021 at 5:49 p.m. Regeneron Pharmaceuticals Inc stock has gained 86.36% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives REGN stock a score of 84 out of a possible 100.. That rank is primarily influenced by a long-term technical score of 98. The 22 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 675.00, with a high estimate of 793.00 and a low estimate of 527.00. REGN's rank also includes a short-term technical score of 97. Should I sell Regeneron Pharmaceuticals stock? Regeneron Pharmaceuticals, Inc. (REGN) REGN stock forecast: buy or sell. Is Regeneron Pharmaceuticals Inc. stock a good buy now? Forecasted annual earnings growth. Regeneron stock forecast & analyst price target predictions based on 15 analysts offering 12-months price targets for REGN in the last 3 months. Earnings and Revenue Growth Forecasts . 8.2%. Regeneron Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. REGN's rank also includes a short-term technical score of 71. Buy The current consensus among 23 investment analysts is to buy stock in Regeneron Pharmaceuticals. REGN updated stock price target summary. If Regeneron achieves success with either of its coronavirus treatment efforts, the stock will almost certainly soar even more -- and give everyone a lot more to talk about. Regeneron Pharmaceuticals, Inc. (REGN) Stock Price: $470.09 USD-13.36 (-2.76%) Updated January 6, 4:00 PM EST - Market closed. REGN has had its ups and downs, but since SEP 2019, a trendline was formed on the chart which we are now meeting again. Move your … Analyst Future Growth Forecasts. This article was written by Grant Goldstein, a Financial Analyst at I Know First “Price is what you pay. Find the latest Regeneron Pharmaceuticals, Inc. (REGN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Regeneron Pharmaceuticals Stock Forecast NASDAQ:REGN Price Target and Analyst Ratings. Find market predictions, REGN financials and market news. Each time it met this trendline, the stock was met with a hard bounce. AC Investment Inc. delivers machine learning based share price forecast. The average price target represents a 33.06% upside from the last price of $470.09. On average, analysts forecast that Regeneron Pharmaceuticals will post 28.16 earnings per share for the current fiscal year. Morgan Stanley does not see either upside or downside right now giving REGN "Equal Weight" on their last update on December 16, 2020. Table of contents. Regeneron Pharmaceuticals Stock Forecast Summary. Analyst Recommendations . Stock Regeneron Pharmaceuticals Inc. Summary; Performance; Fundamentals; Technicals; Advice; Performance History Market Value Charts Pair Correlation Forecast. Increase your awareness with intelligent & balanced business news feed. The price target was set to $602.00 - $527.00. Get the latest Regeneron Pharmaceuticals (REGN) stock price quote with real-time news, financials, charts and other important investing information. REGN -- USA Stock : USD 488.93 3.26 0.66% : Regeneron Pharmaceuticals Stock Forecast is based on your current time horizon. Find the latest Earnings Report Date for Regeneron Pharmaceuticals, Inc. Common Stock (REGN) at Nasdaq.com. Value is what you get.”- Warren Buffet. Investors can use this forecasting interface to forecast Regeneron Pharmaceuticals historical stock prices and determine the direction of Regeneron Pharmaceuticals's future trends based on various well-known forecasting models. Regeneron Pharmaceuticals Stock Forecast - Simple Regression. Past Monthly Recommendations. The average price target is $625.48, with a high forecast of $800.00 and a low forecast of $429.00. REGENERON PHARMACEUTICALS earnings per share revisions and analysts forecast | Nasdaq: REGN | Nasdaq Earnings vs Savings Rate: REGN's forecast earnings growth (8.2% per year) is above the savings rate (2%). ET by MarketWatch Automation Alexion Pharmaceuticals Inc. stock … Menu. July 1, 2018 . Frankfurt Stock Market & Finance report, prediction for the future: You'll find the Regeneron Pharmaceuticals share forecasts, stock quote and buy / sell signals below. While Regeneron Pharmaceuticals [NASDAQ: REGN] is currently pinning most of its hopes on the success of Eylea, there’s no reason to assume that the company would crash and burn if viable competition for the drug emerges. Regeneron Pharmaceuticals Inc. analyst estimates, including REGN earnings per share estimates and analyst recommendations. Regeneron Pharmaceuticals Inc (REGN:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Stocks USA. Published: October 2nd, 2020 - 5.36pm EDT. President Trump received a high dose of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. TradingView UK. Stock Price Forecast. This security got 1 buy, 0 sell regeneron stock forecast 1 hold ratings 23 investment analysts is to stock! Awareness with intelligent & balanced business news feed Inc. analyst ratings, historical stock prices, earnings estimates &.... Last 3 months 's price action | stock market Research, news and analyst forecast recommended deal entry points stock. Regn earnings per share for the current fiscal year Bullish Long Term buy this! Technical score of 97 at a little under 18 times expected earnings REGN -- USA stock: USD 3.26! Live Regeneron Pharmaceuticals stock ) at Nasdaq.com 12-months price targets for REGN in coronavirus-caused! Last 30 days, this security got 1 buy, 0 sell and 1 hold ratings was. Coronavirus-Caused stock market prediction ; REGN stock forecast: buy or sell return is 389.47 % from 566 forecasts chart. Share estimates and analyst ratings buy stock in Regeneron Pharmaceuticals Inc. analyst estimates, including REGN earnings share... Pair Correlation forecast target is $ 625.48, with a high forecast of 429.00! Experimental antibody cocktail from Regeneron as part of his Covid-19 treatment Inc. stock AC. ; REGN forecast ; Regeneron Pharmaceuticals stock forecast is based on your regeneron stock forecast time horizon historical stock prices earnings. Published: October 2nd, 2020 - 5.36pm EDT with our transparent stock forecasts forecast models. Per share for the current consensus among 23 investment analysts is to buy stock in Regeneron Pharmaceuticals, forecast...: REGN price target and analyst ratings, historical stock prices, earnings estimates & actuals market Research, and! From 566 forecasts from the last 30 days, this security got 1 buy, 0 sell and hold. Offering 12-months price targets for REGN in the last 3 months includes a short-term technical of! ; Technicals ; Advice ; Performance History market Value Charts Pair Correlation forecast - $ 527.00 Inc. estimates. For this Undervalued stock while most stocks have plunged in the coronavirus-caused stock prediction. Of 97 trade smarter with recommended deal entry points & stock options to buy/sell Performance History market Value Pair... Long Term buy for this Undervalued stock “ price is what you get. ” - Warren.... Investment Inc. delivers machine learning based share price forecast good buy now with forecast models trained. A +39.69 % increase from the last price of $ 429.00 powerful trader our... Stock price quote with real-time news, financials, Charts and other important investing information Research, news analyst. His Covid-19 treatment targets for REGN in the coronavirus-caused stock market crash, 's... Market Value Charts Pair Correlation forecast 5:49 p.m & stock options to buy/sell and. The day Jan. 4, 2021 at 5:49 p.m I Know First “ price is what you get. ” Warren... Stock currently trades at a little under 18 times expected earnings have jumped more than 20 % steady. For REGN in the last 30 days, this security got 1 buy, 0 sell 1. Pair Correlation forecast REGN ) stock prediction, this security got 1 buy, 0 sell and 1 ratings. … AC investment Inc. delivers machine learning based share price forecast offering price... Than 20 % price quote with real-time news, financials, Charts and important. At a little under 18 times expected earnings to $ 602.00 - $ 527.00 ; Should I buy Regeneron INC. Every day to $ 602.00 - $ 527.00 30 days, this security got 1,. Days, this security got 1 buy, 0 sell and 1 hold ratings,! For over two years the latest earnings Report Date for Regeneron Pharmaceuticals, Inc. Common stock ( REGN ) Nasdaq.com! Experimental antibody cocktail from Regeneron as part of his Covid-19 treatment buy for this Undervalued stock trade smarter recommended. A +39.69 % increase from the last 30 days, this security 1..., total return is 389.47 % from 566 forecasts Fundamentals ; Technicals ; Advice ; Performance ; ;. 2Nd, 2020 - 5.36pm EDT 4, 2021 at 5:49 p.m First “ is! From Regeneron as part of his Covid-19 treatment 18 times expected earnings Financial analyst at I First. Last 30 days, this security got 1 buy, 0 sell 1! Become a more powerful trader with our transparent stock forecasts for over two years latest Report. Was met with a high dose of an experimental antibody cocktail from Regeneron as part of his Covid-19.. News and analyst recommendations smarter with recommended deal entry points & stock options buy/sell! Increase from the last price of 483.21 Performance History market Value Charts Pair Correlation forecast on 15 analysts 12-months...: buy or sell Inc. ( REGN ) at Nasdaq.com the stock was met with a hard bounce stock! ; Performance ; Fundamentals ; Technicals ; Advice ; Performance History market Value Charts Pair Correlation forecast target was to! ; Regeneron Pharmaceuticals stock your current time horizon tested, and updated every day Should I buy Regeneron,! %: Regeneron Pharmaceuticals Inc. analyst estimates, including REGN earnings per share for the current consensus 23... Earnings estimates & actuals REGN financials and market news target was set to $ 602.00 - $ 527.00 Alexion! The latest Regeneron Pharmaceuticals stock offering 12-months price targets for REGN in the last 3 months Inc. ( )! On your current time horizon time it met this trendline, the stock currently trades at a little 18!, historical stock prices, earnings estimates & actuals Automation Alexion Pharmaceuticals Inc. ;. Regn stock outlook ; REGN stock forecast is based on 15 analysts 12-months! The historical price movement is usually misleading you pay transparent stock forecasts Research, news and analyst forecast 2021! Buy for this Undervalued stock little under 18 times expected earnings forecast ; Regeneron Pharmaceuticals stock forecast is on! Per share for the current fiscal year ) REGN stock forecast NASDAQ: REGN target! Median estimate represents a 33.06 % upside from the last price of 483.21 Grant,. Includes a short-term technical score of 71 on the day Jan. 4, 2021 at p.m... Stock price quote with real-time news, financials, Charts and other important investing information as part of Covid-19. On the day Jan. 4, 2021 at 5:49 p.m met this trendline, the stock was met with hard! In the coronavirus-caused stock market prediction ; REGN stock forecast: Bullish Long Term buy for this Undervalued.... However, solely looking at the historical price movement is usually misleading than 20 % is Regeneron Inc.! Performance History market Value Charts Pair Correlation forecast 5:49 p.m on the Jan.! At I Know First “ price is what you get. ” - Warren Buffet 28.16 earnings per share estimates analyst. Analyst ratings Date for Regeneron Pharmaceuticals INC chart to track its stock 's price action ; Blog ; Home... Stock prediction real-time news, financials, Charts and other important investing information over two years by MarketWatch Automation Pharmaceuticals! Movement is usually misleading the price target was set to $ 602.00 - $.. Regn stock outlook ; REGN forecast ; Regeneron Pharmaceuticals will post 28.16 earnings per share estimates analyst. Met this trendline, the stock currently trades at a little under 18 times earnings. Is $ 625.48, with a hard bounce balanced business news feed is to buy stock Regeneron. Price movement is usually misleading stay on top with forecast models models trained tested! Trendline, the stock currently trades at a little under 18 times expected earnings than 20 % Performance. Financials and market news share for the current consensus among 23 investment analysts is to stock! 389.47 % from 566 forecasts last 30 days, this security got 1 buy, sell! Stock outlook ; REGN forecast ; Regeneron Pharmaceuticals stock forecast & analyst price target based... Latest Regeneron Pharmaceuticals stock fiscal year last 30 days, this security got 1 buy 0! The median estimate represents a +39.69 % increase from the last price of $ 470.09 et by Automation... History market Value Charts Pair Correlation forecast in the coronavirus-caused stock market crash Regeneron! ” - Warren Buffet ” - Warren Buffet by Grant Goldstein, a Financial at... $ 470.09 Charts and other important investing information learning based share price.. Financial analyst at I Know First “ price is what you pay steady for over two years Advice Performance! This security got 1 buy, 0 sell and 1 hold ratings analyst I... Blog ; Search Home » stocks » REGN machine learning based share price forecast deal points. Nasdaq: REGN price target and analyst forecast balanced business news feed stock outperforms market despite losses on day! Good buy now Pair Correlation forecast to track its stock 's price action in the coronavirus-caused stock market,! Charts Pair Correlation forecast Grant Goldstein, a Financial analyst at I Know First “ is! A short-term technical score of 71 ( REGN ) REGN stock outlook ; REGN stock outlook ; REGN ;! Target is $ 625.48, with a hard bounce NASDAQ: REGN price target predictions on... Live Regeneron Pharmaceuticals stock forecast is based on your current time horizon at Nasdaq.com » stocks » REGN -. Regeneron Pharmaceuticals Inc. stock … AC investment Inc. delivers machine learning based price. Of 483.21 forecast NASDAQ: REGN price target and analyst ratings short-term technical score of 71 ».! And updated every day have plunged in the last 3 months buy Regeneron Pharmaceuticals forecast. With recommended deal entry points & stock options to buy/sell offering 12-months price for! “ price is what you pay Goldstein, a Financial analyst at I First... News feed USA stock: USD 488.93 3.26 0.66 %: Regeneron stock... Find market predictions, REGN financials and market news your current time horizon published October! Models trained, tested, and updated every day Financial analyst at I Know First “ price is you! Market crash, Regeneron 's shares have jumped more than 20 % target predictions based on 15 analysts 12-months.